Summary
Researchers reviewed the literature on ginger (Zingiber officinale) and its pharmacodynamic properties in the prevention and treatment of colorectal cancer (CRC). Ginger is recognized for its bioactive activities, including anti-inflammatory, antioxidant, and anticancer properties. Identified mechanisms include the inhibition of CRC cell proliferation, blocking of the cell cycle, induction of apoptosis, and suppression of invasion and cell migration. Additionally, ginger may enhance the effects of chemotherapeutic drugs. The research highlights the relevance of ginger as a natural option for the prevention and clinical treatment of CRC, supporting its use in daily practice. However, it is important to consider that most data come from clinical studies, in vitro experiments, and animal models, which limits the generalization of results to humans.
Key points
- Ginger has anti-inflammatory and antioxidant properties that may help in the prevention of colorectal cancer.
- Mechanisms such as inhibition of cell proliferation and induction of apoptosis have been observed in studies with colorectal cancer cells.
- Ginger may enhance the efficacy of chemotherapeutic drugs in the treatment of colorectal cancer.
✦ For you
Consider including ginger in your daily diet, whether in teas, seasonings, or juices, to take advantage of its beneficial properties. Additionally, observe how your body reacts to this inclusion and maintain a balanced diet. If you have concerns about intestinal health or persistent symptoms, seek a qualified health professional.
For practitionersExpand
In clinical practice, ginger (Zingiber officinale) can be considered as a support in the prevention and treatment of colorectal cancer. Evaluate the inclusion of ginger in phytotherapeutic formulas, especially in patients undergoing chemotherapy, to enhance therapeutic effects. Be aware of contraindications and interactions with other medications.